Lorenzo Gerratana, Carmine De Angelis, Fabiola Giudici, Alessandro La Torraca, Vincenzo Montesarchio, Simona Gasparro, Laura Biganzoli, Silvia Castellani, Emilia Sicari, Aldo Caltavituro, Lorenzo Foffano, Paola Lucia Poletti, Carminia Maria Della Corte, Giuseppina R. R. Ricciardi, Giuseppe Cairo, Teresa Gamucci, Lucia Del Mastro, Mario Giuliano, Fabio Puglisi, Grazia Arpino. "Prognostic profiling of hormone receptor–positive, HER2-negative (HR+/HER2-) metastatic breast cancer (MBC) treated with CDK4/6 inhibitors beyond progression (BP): A synthetic control arm biomarker analysis.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e13068